Evaluation of the antinociceptive effects of a selection of triazine derivatives in mice
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background: The authors showed in a previous study that some novel triazine derivatives had an anti-inflammatory effect. The present study was designed to evaluate the antinociceptive effect of five out of nine compounds including two vanillintriazine (5c and 5d) and three phenylpyrazole-triazine (10a, 10b, 10e) derivatives which showed the best anti-inflammatory effect. Methods: Male Swiss mice (25–30 g) were used. To assess the antinociceptive effect, acetic acid-writhing, formalin, and hot plate tests were used after intraperitoneal injection of each compound. Results: All compounds significantly (P < 0.001) reduced acetic acid-induced writhing at tested doses (50, 100, and 200 mg/kg). Also, the percent inhibition of writhing in the acetic acid test showed that at the maximum tested dose of these compounds (200 mg/kg), the order of potencies is as follows: 10b > 10a > 10e > 5d > 5c. In the formalin test, compounds 5d, 10a, and 10e showed an antinociceptive effect in the acute phase and all compounds were effective in the chronic phase. In the hot plate test, compounds 5c, 5d, and 10a demonstrated an antinociceptive effect. Conclusions: The results clearly showed that both vanillin-triazine and phenylpyrazole- triazine derivatives had an antinociceptive effect. Also, some compounds which showed activity in the early phase of formalin test as well as in the hot plate test could control acute pain in addition to chronic or inflammatory pain.
Abstract
Background: The authors showed in a previous study that some novel triazine derivatives had an anti-inflammatory effect. The present study was designed to evaluate the antinociceptive effect of five out of nine compounds including two vanillintriazine (5c and 5d) and three phenylpyrazole-triazine (10a, 10b, 10e) derivatives which showed the best anti-inflammatory effect. Methods: Male Swiss mice (25–30 g) were used. To assess the antinociceptive effect, acetic acid-writhing, formalin, and hot plate tests were used after intraperitoneal injection of each compound. Results: All compounds significantly (P < 0.001) reduced acetic acid-induced writhing at tested doses (50, 100, and 200 mg/kg). Also, the percent inhibition of writhing in the acetic acid test showed that at the maximum tested dose of these compounds (200 mg/kg), the order of potencies is as follows: 10b > 10a > 10e > 5d > 5c. In the formalin test, compounds 5d, 10a, and 10e showed an antinociceptive effect in the acute phase and all compounds were effective in the chronic phase. In the hot plate test, compounds 5c, 5d, and 10a demonstrated an antinociceptive effect. Conclusions: The results clearly showed that both vanillin-triazine and phenylpyrazole- triazine derivatives had an antinociceptive effect. Also, some compounds which showed activity in the early phase of formalin test as well as in the hot plate test could control acute pain in addition to chronic or inflammatory pain.
참고문헌 (32)
- Wongrakpanich S, "A comprehensive review of non-steroidal antiinflammatory drug use in the elderly", Aging Dis, 9, pp.143~150 (2018)
- Clària J, "Cyclooxygenase-2 biology", Curr Pharm Des, 9, pp.2177~2190 (2003)
- Smith WL, "Cyclooxygenases : structural, cellular, and molecular biology", Annu Rev Biochem, 69, pp.145~182 (2000)
- Gupta S, "An update on specific COX-2 inhibitors : the COXIBs", Bull Rheum Dis, 50, pp.1~4 (2001)
- Vishwakarma RK, "The development of COX-1 and COX-2 inhibitors : a review", Int J Pharm Sci Res, 11, pp.3544~3555 (2020)
- Silverstein FE, "Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib Long-term Arthritis Safety Study", JAMA, 284, pp.1247~1255 (2000)
- Bombardier C, "Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group", N Engl J Med, 343, pp.1520~1528 (2000)
- Laine L, "Gastrointestinal effects of NSAIDs and coxibs", J Pain Symptom Manage, 25(2 Suppl), pp.S32~S40 (2003)
- Kearney PM, "Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials", BMJ, 332, pp.1302~1308 (2006)
- Arora M, "Structural investigation on the selective COX-2 inhibitors mediated cardiotoxicity : a review", Life Sci, 251, pp.117631~ (2020)
- Salvo F, "Cardiovascular and gastrointestinal safety of NSAIDs : a systematic review of meta-analyses of randomized clinical trials", Clin Pharmacol Ther, 89, pp.855~866 (2011)
- Olry de Labry Lima A, "Safety considerations during prescription of nonsteroidal anti-inflammatory drugs(NSAIDs), through a review of systematic reviews", An Sist Sanit Navar, 44, pp.261~273 (2021)
- White WB, "Cardiovascular thrombotic events in arthritis trials of the cyclooxygenase-2inhibitor celecoxib", Am J Cardiol, 92, pp.411~418 (2003)
- Grosser T, "Biological basis for the cardiovascular consequences of COX-2 inhibition : therapeutic challenges and opportunities", J Clin Invest, 116, pp.4~15 (2006)
- Marsico F, "NSAIDs and cardiovascular risk", J Cardiovasc Med (Hagerstown), 18(Suppl 1: Special Issue on The State of the Art for the Practicing Cardiologist:The 2016 Conoscere E Curare Il Cuore (CCC) Proceedings from the CLI Foundation), pp.e40~e43 (2017)
- Sondhi SM, "Heterocyclic compounds as anti-inflammatory agents", Curr Bioact Compd, 3, pp.91~108 (2007)
- Kurumbail RG, "Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents", Nature, 384, pp.644~648 (1996)
- Zarghi A, "Selective COX-2 inhibitors : a review of their structure-activity relationships", Iran J Pharm Res, 10, pp.655~683 (2011)
- triazine-3, 4-dione derivatives determined by reversed-phase HPLC and computational methods, "Eur J Med Chem", 2010, 2644~2649
- triazines, "Eur J Med Chem", 2005, 127~134
- Asadi P, "Design, synthesis, biological evaluation, and molecular docking study on triazine based derivatives as anti-inflammatory agents", J Mol Struct, 1243, pp.130760~ (2021)
- Gawade SP, "Acetic acid induced painful endogenous infliction in writhing test on mice", J Pharmacol Pharmacother, 3, pp.348~ (2012)
- Tjølsen A, "The formalin test : an evaluation of the method", Pain, 51, pp.5~17 (1992)
- Hajhashemi V, "Effect of glibenclamide on antinociceptive effects of antidepressants of different classes", Clinics (Sao Paulo), 66, pp.321~325 (2011)
- Hajhashemi V, "Antinociceptive effect of clavulanic acid and its preventive activity against development of morphine tolerance and dependence in animal models", Res Pharm Sci, 9, pp.315~321 (2014)
- Hajhashemi V, "Antinociceptive and anti-inflammatory activities of Bunium persicum essential oil, hydroalcoholic and polyphenolic extracts in animal models", Pharm Biol, 49, pp.146~151 (2011)
- Hunskaar S, "The formalin test in mice : dissociation between inflammatory and non-inflammatory pain", Pain, 30, pp.103~114 (1987)
- Malmberg AB, "Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat", J Pharmacol Exp Ther, 263, pp.136~146 (1992)
- Cheol Hun Choi, "Roles of Opioid Receptor Subtype in the Spinal Antinociception of Selective Cyclooxygenase 2 Inhibitor", The Korean Journal of Pain, 23(4), pp.236~241 (2010), 대한통증학회
- Gunn A, "The influence of non-nociceptive factors on hot-plate latency in rats", J Pain, 12, pp.222~227 (2011)
- Malmberg AB, "Models of nociception : hot-plate, tail-flick, and formalin tests in rodents", Curr Protoc Neurosci, 6, pp.8.9.1~15 (1999)
- Le Bars D, "Animal models of nociception", Pharmacol Rev, 53, pp.597~652 (2001)